OpenPV Signal Explorer
FAERS disproportionality dashboard
← All drugs
Drug

Octreotide

324 flagged reaction(s) · 11,699 total co-reports · max PRR 21.7
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Metastases To Liver 101 21.7 22.1 signal
2 Blood Pressure Systolic Increased 87 16.7 16.9 signal
3 Body Temperature Decreased 38 14.4 14.5 signal
4 Hypoglycaemia 164 12.7 13.0 signal
5 Drug Ineffective For Unapproved Indication 185 12.5 12.9 signal
6 Small Intestinal Obstruction 33 10.1 10.1 signal
7 Metastases To Bone 42 9.6 9.7 signal
8 Hepatic Encephalopathy 23 9.2 9.3 signal
9 Malignant Neoplasm Progression 248 9.1 9.5 signal
10 Therapy Non-responder 103 8.7 8.8 signal
11 Malnutrition 25 8.4 8.5 signal
12 Neoplasm Progression 77 8.2 8.3 signal
13 Neoplasm 25 8.1 8.2 signal
14 Ascites 62 7.9 8.0 signal
15 Cholelithiasis 68 7.8 7.9 signal
16 Sinus Bradycardia 20 7.7 7.8 signal
17 Cardiomyopathy 27 6.8 6.9 signal
18 Generalised Oedema 22 6.7 6.7 signal
19 Upper Gastrointestinal Haemorrhage 30 6.7 6.7 signal
20 Needle Issue 49 6.4 6.5 signal
21 Intestinal Obstruction 63 6.3 6.4 signal
22 Hypocalcaemia 29 5.8 5.8 signal
23 Flatulence 86 5.7 5.8 signal
24 Electrolyte Imbalance 17 5.5 5.6 signal
25 Therapy Partial Responder 22 5.5 5.5 signal
26 Hyperglycaemia 53 5.5 5.5 signal
27 Ventricular Tachycardia 24 5.4 5.4 signal
28 Nephropathy Toxic 16 5.4 5.4 signal
29 Hepatomegaly 14 5.3 5.3 signal
30 Clostridium Difficile Colitis 15 5.3 5.3 signal
31 Multiple Organ Dysfunction Syndrome 39 5.2 5.3 signal
32 Flank Pain 13 5.2 5.2 signal
33 Hypercholesterolaemia 13 5.1 5.1 signal
34 Disease Progression 160 5.1 5.2 signal
35 Blood Calcium Decreased 15 5.0 5.0 signal
36 Acute Hepatic Failure 18 5.0 5.0 signal
37 Cytomegalovirus Infection 22 5.0 5.0 signal
38 Flushing 135 5.0 5.1 signal
39 Hepatic Failure 39 4.8 4.9 signal
40 Motor Dysfunction 13 4.8 4.8 signal
41 Injection Site Extravasation 16 4.8 4.8 signal
42 Blood Iron Decreased 15 4.8 4.8 signal
43 Melaena 28 4.8 4.8 signal
44 Pericardial Effusion 29 4.7 4.7 signal
45 Intestinal Perforation 14 4.7 4.7 signal
46 Gastrointestinal Haemorrhage 100 4.5 4.5 signal
47 Thyroid Disorder 18 4.4 4.4 signal
48 Rebound Effect 13 4.3 4.3 signal
49 Coagulopathy 19 4.3 4.3 signal
50 Vitamin D Deficiency 11 4.2 4.2 signal
51 Metastases To Lung 13 4.2 4.2 signal
52 Heart Rate Decreased 39 4.1 4.2 signal
53 Hypomagnesaemia 15 4.1 4.1 signal
54 Injection Site Discomfort 11 4.0 4.0 signal
55 Ileus 13 4.0 4.0 signal
56 Electrocardiogram Qt Prolonged 38 4.0 4.0 signal
57 Injection Site Mass 38 3.9 3.9 signal
58 Proteinuria 19 3.8 3.8 signal
59 Hypokalaemia 46 3.8 3.8 signal
60 Abdominal Pain 231 3.7 3.8 signal
61 Toxic Skin Eruption 10 3.7 3.7 signal
62 Abdominal Distension 102 3.7 3.7 signal
63 Cardiogenic Shock 14 3.7 3.7 signal
64 Bradycardia 52 3.7 3.7 signal
65 Respiratory Depression 12 3.7 3.7 signal
66 Haemorrhoids 19 3.6 3.7 signal
67 Device Related Infection 15 3.6 3.6 signal
68 Blood Pressure Decreased 64 3.6 3.6 signal
69 Encephalopathy 23 3.5 3.5 signal
70 Blood Potassium Decreased 28 3.5 3.5 signal
71 Frequent Bowel Movements 25 3.5 3.5 signal
72 Mass 13 3.5 3.5 signal
73 Acute Kidney Injury 141 3.5 3.5 signal
74 Hospice Care 9 3.4 3.4 signal
75 Pulmonary Hypertension 19 3.4 3.4 signal
76 Musculoskeletal Chest Pain 14 3.4 3.4 signal
77 Septic Shock 39 3.4 3.4 signal
78 Drug Resistance 23 3.4 3.4 signal
79 Hypothermia 9 3.3 3.3 signal
80 Product Prescribing Issue 18 3.3 3.3 signal
81 Cholecystectomy 10 3.3 3.3 signal
82 Sepsis 98 3.3 3.3 signal
83 Urinary Retention 29 3.3 3.3 signal
84 Iron Deficiency Anaemia 8 3.3 3.3 signal
85 Pleural Effusion 53 3.3 3.3 signal
86 Blood Pressure Increased 132 3.2 3.3 signal
87 Hepatic Cirrhosis 16 3.2 3.2 signal
88 Diarrhoea 547 3.2 3.4 signal
89 Disseminated Intravascular Coagulation 12 3.2 3.2 signal
90 Bacteraemia 10 3.2 3.2 signal
91 Colitis 32 3.2 3.2 signal
92 Cholecystitis 10 3.2 3.2 signal
93 Off Label Use 727 3.1 3.5 signal
94 Cytopenia 10 3.1 3.1 signal
95 Sleep Apnoea Syndrome 16 3.1 3.1 signal
96 Dizziness Postural 8 3.1 3.1 signal
97 Leukocytosis 15 3.1 3.1 signal
98 Gastroenteritis 12 3.1 3.1 signal
99 Quality Of Life Decreased 11 3.1 3.1 signal
100 Blood Bilirubin Increased 22 3.0 3.0 signal
101 Eating Disorder 17 3.0 3.0 signal
102 Metabolic Acidosis 25 3.0 3.0 signal
103 Cholestasis 15 2.9 2.9 signal
104 Clostridium Difficile Infection 17 2.9 2.9 signal
105 Gallbladder Disorder 14 2.9 2.9 signal
106 Thrombocytopenia 87 2.9 3.0 signal
107 Rib Fracture 16 2.9 2.9 signal
108 Stomatitis 47 2.9 2.9 signal
109 Hyperkalaemia 27 2.9 2.9 signal
110 Cardiac Arrest 64 2.9 2.9 signal
111 Ejection Fraction Decreased 12 2.9 2.9 signal
112 Palmar-plantar Erythrodysaesthesia Syndrome 18 2.9 2.9 signal
113 Haematoma 20 2.9 2.9 signal
114 Blood Alkaline Phosphatase Increased 19 2.9 2.9 signal
115 Gastrointestinal Carcinoma 7 2.9 2.9 signal
116 Renal Pain 8 2.8 2.8 signal
117 Product Packaging Issue 7 2.8 2.8 signal
118 Pancytopenia 42 2.8 2.8 signal
119 Abdominal Pain Lower 19 2.8 2.8 signal
120 Heart Rate Irregular 17 2.8 2.8 signal
121 Diarrhoea Haemorrhagic 7 2.8 2.8 signal
122 Haematemesis 19 2.8 2.8 signal
123 Glomerular Filtration Rate Decreased 9 2.8 2.8 signal
124 Skin Laceration 8 2.8 2.8 signal
125 Sputum Discoloured 7 2.8 2.8 signal
126 Pneumonitis 20 2.8 2.8 signal
127 Productive Cough 35 2.8 2.8 signal
128 Aspiration 8 2.8 2.8 signal
129 Pallor 20 2.7 2.8 signal
130 Product Use In Unapproved Indication 179 2.7 2.8 signal
131 Gastrointestinal Pain 8 2.7 2.7 signal
132 International Normalised Ratio Increased 21 2.7 2.7 signal
133 Mucosal Inflammation 19 2.7 2.7 signal
134 Dehydration 97 2.7 2.8 signal
135 Treatment Failure 59 2.7 2.7 signal
136 Haemoptysis 20 2.7 2.7 signal
137 Kidney Infection 14 2.7 2.7 signal
138 Hypoxia 25 2.7 2.7 signal
139 Blood Glucose Decreased 34 2.6 2.7 signal
140 Drug Reaction With Eosinophilia And Systemic Symptoms 18 2.6 2.6 signal
141 Metastases To Central Nervous System 9 2.6 2.6 signal
142 Multi-organ Failure 12 2.6 2.6 signal
143 Decreased Appetite 158 2.6 2.6 signal
144 Renal Impairment 57 2.6 2.6 signal
145 Hernia 13 2.5 2.5 signal
146 Petechiae 7 2.5 2.5 signal
147 Pancreatitis Acute 15 2.5 2.5 signal
148 Haematochezia 37 2.5 2.5 signal
149 Respiratory Failure 49 2.5 2.5 signal
150 General Physical Health Deterioration 77 2.5 2.5 signal
151 Weight Decreased 187 2.5 2.6 signal
152 Adrenal Insufficiency 8 2.5 2.5 signal
153 Dyspnoea Exertional 25 2.5 2.5 signal
154 Tachypnoea 9 2.5 2.5 signal
155 Renal Disorder 31 2.5 2.5 signal
156 Red Blood Cell Count Decreased 19 2.5 2.5 signal
157 Nephrolithiasis 30 2.5 2.5 signal
158 Liver Disorder 29 2.5 2.5 signal
159 Febrile Neutropenia 43 2.4 2.4 signal
160 Therapeutic Response Decreased 39 2.4 2.4 signal
161 Hospitalisation 98 2.4 2.4 signal
162 Musculoskeletal Discomfort 11 2.4 2.4 signal
163 Nephropathy 6 2.4 2.4 no signal
164 Blood Glucose Fluctuation 7 2.4 2.4 signal
165 Body Temperature Increased 13 2.4 2.4 signal
166 Hepatotoxicity 14 2.4 2.4 signal
167 Sciatica 10 2.4 2.4 signal
168 Oedema Peripheral 77 2.4 2.4 signal
169 Supraventricular Tachycardia 6 2.3 2.4 no signal
170 Product Use Issue 117 2.3 2.4 signal
171 Cold Sweat 11 2.3 2.3 signal
172 Therapy Change 6 2.3 2.3 no signal
173 Haemoglobin Decreased 64 2.3 2.3 signal
174 Scab 7 2.3 2.3 no signal
175 Internal Haemorrhage 7 2.3 2.3 no signal
176 Drug Interaction 97 2.3 2.3 signal
177 Tooth Infection 8 2.3 2.3 signal
178 Pulmonary Congestion 8 2.3 2.3 signal
179 Gastric Haemorrhage 7 2.3 2.3 no signal
180 Contusion 58 2.3 2.3 signal
181 Pneumocystis Jirovecii Pneumonia 6 2.2 2.2 no signal
182 Faeces Discoloured 13 2.2 2.2 signal
183 Candida Infection 10 2.2 2.2 signal
184 Hypotension 120 2.2 2.3 signal
185 Cardiac Failure 48 2.2 2.2 signal
186 Contraindicated Product Administered 18 2.2 2.2 signal
187 Blood Glucose Abnormal 11 2.2 2.2 signal
188 Type 2 Diabetes Mellitus 20 2.2 2.2 signal
189 Disease Recurrence 28 2.2 2.2 signal
190 Ear Discomfort 6 2.2 2.2 no signal
191 Pancreatitis 31 2.2 2.2 signal
192 Inappropriate Schedule Of Product Administration 103 2.2 2.2 signal
193 Hyperbilirubinaemia 6 2.2 2.2 no signal
194 Nocturia 7 2.2 2.2 no signal
195 Lower Respiratory Tract Infection 26 2.1 2.2 signal
196 Syringe Issue 10 2.1 2.1 signal
197 Pneumothorax 9 2.1 2.1 signal
198 Hypercalcaemia 7 2.1 2.1 no signal
199 Anaemia 108 2.1 2.1 signal
200 Lymphocyte Count Decreased 10 2.1 2.1 signal
201 Blood Triglycerides Increased 10 2.1 2.1 signal
202 Premature Baby 17 2.1 2.1 signal
203 Hepatocellular Injury 8 2.1 2.1 no signal
204 Gout 10 2.1 2.1 signal
205 Hair Colour Changes 7 2.1 2.1 no signal
206 Hyperthyroidism 8 2.1 2.1 no signal
207 Syncope 55 2.1 2.1 signal
208 Dysstasia 16 2.0 2.0 signal
209 Abdominal Pain Upper 112 2.0 2.1 signal
210 Unresponsive To Stimuli 14 2.0 2.0 signal
211 Brain Neoplasm 5 2.0 2.0 no signal
212 Fluid Overload 8 2.0 2.0 no signal
213 Therapy Interrupted 37 2.0 2.0 signal
214 Colon Cancer 8 2.0 2.0 no signal
215 Drug Ineffective 693 2.0 2.1 no signal
216 Circulatory Collapse 9 2.0 2.0 no signal
217 Shock 12 2.0 2.0 no signal
218 Eructation 10 2.0 2.0 no signal
219 Posterior Reversible Encephalopathy Syndrome 5 2.0 2.0 no signal
220 Cytokine Release Syndrome 10 2.0 2.0 no signal
221 Epilepsy 16 2.0 2.0 no signal
222 Myocardial Ischaemia 6 2.0 2.0 no signal
223 Gastrointestinal Disorder 46 1.9 2.0 no signal
224 Injection Site Swelling 39 1.9 1.9 no signal
225 Gait Inability 17 1.9 1.9 no signal
226 Rhabdomyolysis 21 1.9 1.9 no signal
227 Product Administration Error 10 1.9 1.9 no signal
228 Platelet Count Decreased 53 1.9 1.9 no signal
229 Haematuria 17 1.9 1.9 no signal
230 Pelvic Pain 9 1.9 1.9 no signal
231 Myelodysplastic Syndrome 7 1.8 1.8 no signal
232 Diabetes Mellitus 37 1.8 1.8 no signal
233 Hyperhidrosis 62 1.8 1.8 no signal
234 Ill-defined Disorder 29 1.8 1.8 no signal
235 Blood Urine Present 9 1.8 1.8 no signal
236 Post Procedural Complication 9 1.8 1.8 no signal
237 Wound 13 1.8 1.8 no signal
238 Feeling Cold 13 1.7 1.7 no signal
239 Altered State Of Consciousness 10 1.7 1.7 no signal
240 Bone Pain 27 1.7 1.7 no signal
241 Blood Pressure Abnormal 9 1.7 1.7 no signal
242 Injection Site Haemorrhage 36 1.7 1.7 no signal
243 Death 388 1.7 1.7 no signal
244 Haemorrhage 47 1.7 1.7 no signal
245 Jaundice 12 1.7 1.7 no signal
246 Fistula 5 1.7 1.7 no signal
247 Mood Altered 12 1.7 1.7 no signal
248 Epistaxis 33 1.6 1.7 no signal
249 Illness 44 1.6 1.6 no signal
250 Injection Site Warmth 9 1.6 1.6 no signal
251 Loss Of Consciousness 56 1.6 1.6 no signal
252 Product Substitution Issue 25 1.6 1.6 no signal
253 Fluid Retention 22 1.6 1.6 no signal
254 Ovarian Cancer 4 1.6 1.6 no signal
255 Spinal Pain 5 1.6 1.6 no signal
256 Squamous Cell Carcinoma 4 1.6 1.6 no signal
257 Leukaemia 4 1.6 1.6 no signal
258 Localised Infection 10 1.5 1.5 no signal
259 Pancreatic Carcinoma 12 1.5 1.5 no signal
260 Drug Effective For Unapproved Indication 12 1.5 1.5 no signal
261 Rash Maculo-papular 9 1.5 1.5 no signal
262 Hip Fracture 13 1.5 1.5 no signal
263 No Therapeutic Response 5 1.5 1.5 no signal
264 Insurance Issue 6 1.5 1.5 no signal
265 Inappropriate Schedule Of Drug Administration 29 1.5 1.5 no signal
266 Brain Injury 4 1.5 1.5 no signal
267 Injection Site Pain 120 1.5 1.5 no signal
268 Hip Arthroplasty 6 1.5 1.5 no signal
269 Poor Quality Product Administered 4 1.5 1.5 no signal
270 Lymphoma 6 1.4 1.4 no signal
271 Injection Site Induration 5 1.4 1.4 no signal
272 Transfusion 4 1.4 1.4 no signal
273 Full Blood Count Abnormal 4 1.4 1.4 no signal
274 Product Dose Omission Issue 108 1.4 1.4 no signal
275 Incorrect Product Storage 5 1.4 1.4 no signal
276 Malignant Melanoma 5 1.4 1.4 no signal
277 Product Dose Omission In Error 10 1.4 1.4 no signal
278 Therapy Cessation 19 1.4 1.4 no signal
279 Neutropenia 50 1.4 1.4 no signal
280 Injection Site Nodule 4 1.4 1.4 no signal
281 Drug Level Increased 6 1.4 1.4 no signal
282 Procedural Pain 10 1.4 1.4 no signal
283 Rash Papular 8 1.3 1.3 no signal
284 Myelosuppression 12 1.3 1.3 no signal
285 Neurotoxicity 6 1.3 1.3 no signal
286 Bone Marrow Failure 7 1.3 1.3 no signal
287 Intentional Dose Omission 9 1.2 1.2 no signal
288 Blood Thyroid Stimulating Hormone Increased 3 1.2 1.2 no signal
289 Nervousness 17 1.2 1.2 no signal
290 Haematotoxicity 3 1.2 1.2 no signal
291 Dementia 9 1.2 1.2 no signal
292 Increased Appetite 6 1.2 1.2 no signal
293 Skin Fissures 6 1.2 1.2 no signal
294 Serotonin Syndrome 6 1.2 1.2 no signal
295 Premature Delivery 5 1.2 1.2 no signal
296 Affect Lability 3 1.2 1.2 no signal
297 Thrombotic Microangiopathy 3 1.2 1.2 no signal
298 Hot Flush 23 1.1 1.1 no signal
299 Crying 11 1.1 1.1 no signal
300 Product Physical Issue 6 1.1 1.1 no signal
301 Drug Effect Incomplete 11 1.1 1.1 no signal
302 Full Blood Count Decreased 6 1.1 1.1 no signal
303 Foetal Exposure During Pregnancy 24 1.1 1.1 no signal
304 Peritonitis 6 1.1 1.1 no signal
305 Neoplasm Malignant 19 1.1 1.1 no signal
306 Blood Glucose Increased 50 1.0 1.0 no signal
307 Lactic Acidosis 8 0.9 0.9 no signal
308 Hepatic Cancer 6 0.9 0.9 no signal
309 Osteonecrosis 8 0.9 0.9 no signal
310 Osteonecrosis Of Jaw 6 0.9 0.9 no signal
311 Myocardial Infarction 41 0.9 0.9 no signal
312 Drug Toxicity 3 0.8 0.8 no signal
313 Diabetic Ketoacidosis 5 0.8 0.8 no signal
314 Synovitis 3 0.6 0.6 no signal
315 Injection Site Urticaria 4 0.6 0.6 no signal
316 Injection Site Bruising 13 0.6 0.6 no signal
317 Therapeutic Response Shortened 5 0.6 0.6 no signal
318 Injection Site Erythema 19 0.6 0.6 no signal
319 Injury Associated With Device 3 0.6 0.6 no signal
320 Renal Cancer 6 0.5 0.5 no signal
321 Incorrect Route Of Drug Administration 4 0.4 0.4 no signal
322 Gynaecomastia 3 0.4 0.4 no signal
323 Breast Cancer 9 0.4 0.4 no signal
324 Drug Dependence 13 0.3 0.3 no signal